SCAN 2019
This autumn the International Neuroendocrine Cancer Alliance INCA invites NET patients and healthcare professionals to scan the access challenges to optimal care for NET patients.
Recent News
NCRI Bone mets research survey
NCUK is happy to support NCRI's programme of work that aims to foster high-quality research on bone metastasis. We would like to invite you to support NCRIs work in this area by providing your views on the key research questions and broader challenges that need to be...
How is secondary Neuroendocrine Cancer treated?
As with more common cancers, the earlier in the development of a primary cancer it is diagnosed, the higher the possibility of cure is. For Secondary Neuroendocrine Cancer there is no cure – HOWEVER, this does not necessarily make this a terminal diagnosis. No...
Neuroendocrine Cancer Clinical Trials
Taking part in a clinical trial can be a big commitment – with more travel to the hospital than normal, extra tests, scans, and an increased number of appointments. Whether you decide to take part in a clinical trial or not, you should receive the highest standard...